Orthotopic Heart and Combined Heart Liver Transplantation: the Ultimate Treatment Option for Failing Fontan Physiology
-
Published:2021-02-04
Issue:1
Volume:8
Page:9-20
-
ISSN:2196-3029
-
Container-title:Current Transplantation Reports
-
language:en
-
Short-container-title:Curr Transpl Rep
Author:
Reardon Leigh C., Lin Jeannette P., VanArsdell Glen S., Kaldas Fady M., Lluri Gentian, Tan Weiyi, Whalen Katrina M., Cruz Daniel, Nsair Ali, Deng Mario C., Moore Melissa A., Laks Hillel, Biniwale Reshma M., Saab Sammy, Baird Andrew, Wilson James M., Lubin Lorraine N., Marijic Jure, Williams Tiffany M., Wray Christopher L., Meltzer Joseph S., Gudzenko Vadim, Kratzert Wolf B., Neelankavil Jacques, Venick Robert S., Aboulhosn Jamil A.ORCID
Abstract
Abstract
Purpose of the Review
This is a comprehensive update on failing Fontan physiology and the role of heart and combined heart and liver transplantation in the current era.
Recent Findings
Single ventricle physiology encompasses a series of rare congenital cardiac abnormalities that are characterized by absence of or hypoplasia of one ventricle. This effectively results in a single ventricular pumping chamber. These abnormalities are rarely compatible with long-term survival if left without surgical palliation in the first few years of life. Surgical treatment of single ventricle physiology has evolved over the past 60 years and is characterized by numerous creative innovations. These include the development of arteriopulmonary shunts, the evolution of partial cavopulmonary connections, and the eventual development of the “Fontan” operation. Regardless of the type of Fontan modification, the long-term consequences of the Fontan operation are predominantly related to chronic central venous hypertension and the multi-organ consequences thereof. Atrial arrhythmias can further compromise this circulation.Patients with single ventricle physiology represent a special sub-segment of congenital cardiac transplants and are arguably the most challenging patients considered for transplantation.
Summary
This review describes in detail the challenges and opportunities of heart and liver transplantation in Fontan patients, as viewed and managed by the experienced team at the Ahmanson/UCLA Adult Congenital Heart Center.
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Nephrology,Hepatology,Immunology,Surgery
Reference33 articles.
1. Ohuchi H. Where is the "optimal" Fontan hemodynamics? Korean Circ J. 2017;47(6):842–57. 2. Aboulhosn J, Child JS. The adult with a Fontan operation. Curr Cardiol Rep. 2007;9(4):331–5. 3. Aboulhosn J, Williams R, Shivkumar K, Barkowski R, Plunkett M, Miner P, et al. Arrhythmia recurrence in adult patients with single ventricle physiology following surgical Fontan conversion. Congenit Heart Dis. 2010;5(5):430–4. 4. Daniels CJ, Bradley EA, Landzberg MJ, Aboulhosn J, Beekman RH III, Book W, et al. Fontan-associated liver disease: proceedings from the American College of Cardiology Stakeholders Meeting, October 1 to 2, 2015, Washington DC. J Am Coll Cardiol. 2017;70(25):3173–94. 5. Gewillig M, Brown SC, Eyskens B, Heying R, Ganame J, Budts W, et al. The Fontan circulation: who controls cardiac output? Interact Cardiovasc Thorac Surg. 2010;10(3):428–33.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|